Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers
Status:
COMPLETED
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the pharmacokinetic characteristics of two octreotide microsphere formulations in healthy Chinese volunteers.
Participants will receive single-dose of either test or reference octreotide microsphere formulations.
Researchers will compare pharmacokinetic characteristics of the two formulations to see if they are bioequivalent.